Bringing the fundamentals into focus…
Back to MiMedx Group, Inc.
How MiMedx Group, Inc. stacks up
MDXG · against 443 other Healthcare companies of similar size
Valuation
54/ 100
Above the middle of the pack.
Ranked #182 of 444 · scores higher than 58% of peers
Bars: peers in each 10-point band of the valuation score38 peers with a valuation score of 50–59, including MDXG · Click a bar to see the companies
Why valuation scores 54?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- Earnings yield is close to the peer norm. Earnings yield: 1.3% vs peer median 1.5%
- EBITDA yield is close to the peer norm. EBITDA yield: 6.7% vs peer median 4.0%
- more free cash flow for the price paid: stronger than 92% of peers. Free cash flow yield: 9.4% vs peer median 0.0%
Metric by metric
Position: dot = MDXG, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | MDXG | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 432 reported | 1.2% | 0.4% | 56% | 30% | |
| EBITDA yieldHigher is better · 449 reported | 5.8% | 3.1% | 60% | 50% | |
| Free cash flow yieldHigher is better · 203 reported | 9.4% | -7.5% | 92% | 20% | |
| Book yieldHigher is better · 442 reported | 45.6% | 48.9% | 46% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around MDXGScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score